Skip to content

A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-522930-29-00
Acronym
358-201-00001
Enrollment
72
Registered
2025-10-31
Start date
2025-11-17
Completion date
Unknown
Last updated
2026-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incomplete Response - Major Depressive Disorder (IR-MDD)

Interventions

None listed

Sponsors

Otsuka Pharmaceutical Development & Commercialization Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026